Novartis (NVS) Total Assets (2006 - 2026)
Novartis (NVS) total assets from Mar 31, 2006 to Mar 31, 2026. The current Novartis (NVS) total assets is $119B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Total Assets
Total Assets
Novartis (NVS) Total Assets CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +10.56% |
| 3 Years TTM | -2.12% |
| 5 Years TTM | -2.56% |
| 10 Years TTM | -1.76% |
| All Time TTM | +2.69% |
Annual Total Assets change of Novartis (NVS)
| Year | Total Assets | Change |
|---|---|---|
| 2025 | $116B | +13.03% |
| 2024 | $102B | +2.30% |
| 2023 | $100B | -14.91% |
| 2022 | $117B | -10.88% |
| 2021 | $132B | -0.30% |
| 2020 | $132B | +11.63% |
| 2019 | $118B | -18.65% |
| 2018 | $146B | +9.38% |
| 2017 | $133B | +2.27% |
| 2016 | $130B | -1.09% |
| 2015 | $132B | +4.92% |
| 2014 | $125B | -0.69% |
| 2013 | $126B | +1.64% |
| 2012 | $124B | +5.72% |
| 2011 | $117B | -4.72% |
| 2010 | $123B | +29.12% |
| 2009 | $96B | +21.97% |
| 2008 | $78B | +3.77% |
| 2007 | $75B | +10.95% |
| 2006 | $68B | N/A |
Comparison Novartis (NVS) total assets with competitors
Novartis (NVS) total assets is $118.53B.
| Ticker | Name | Total Assets | Upside |
|---|---|---|---|
| PFE | Pfizer Inc | $207.62B | +75.16% |
| JNJ | Johnson & Johnson | $200.89B | +69.49% |
| ABBV | Abbvie Inc | $136.46B | +15.13% |
| MRK | Merck & Co Inc | $128.69B | +8.57% |
| SNY | Sanofi | $128.02B | +8.01% |
| LLY | Lilly(Eli) & Company | $116.58B | -1.65% |
| AZN | Astrazeneca plc | $114.02B | -3.81% |
| AMGN | AMGEN Inc | $92.50B | -21.96% |
| BMY | Bristol-Myers Squibb Company | $86.48B | -27.04% |
| GSK | GSK Plc | $82.91B | -30.06% |
| GILD | Gilead Sciences Inc | $56.28B | -52.52% |
| BIIB | Biogen Inc | $29.48B | -75.13% |
| GRFS | Grifols SA | $20.10B | -83.04% |
| OGN | Organon & Company | $13.00B | -89.04% |
| AMRN | Amarin Corp | $645.76M | -99.46% |
| SCLX | Scilex Holding Company | $293.63M | -99.75% |
| MIRA | Mira Pharmaceuticals Inc | $9.46M | -99.99% |
| MDCX | MDCorp | $7.43M | -99.99% |
| MDCXW | Medicus Pharma Ltd warrant | $7.43M | -99.99% |
| NSRX | Nasus Pharma Ltd | $5.00M | -100.00% |